Finally, additional data regarding other predictors and determinants of CKD progression, such as use of angiotensin converting enzyme inhibitors and sodium glucose co-transporter 2 inhibitors, fluctuations in blood pressure or intravascular volume, active tobacco use, and adherence to a diet low in animal protein were unavailable [37–39]. The gene discussed is ACE; the disease is chronic kidney disease.